Prognostic factors in oral squamous cell carcinoma. A review of the literature

Anticancer Research

Volumn 19, Issue 4 C, 1999, Pages 3503-3510

  Tralongo, Vincenzo ^a,b   Rodolico, Vito ^a   Luciani, Andrea ^a   Marra, Giacinto ^a   Daniele, Elio ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b NONE   (Italy)

Author keywords

Head and neck tumors; Oral cancer; Oral squamous cell carcinoma; Prognostic factors

Indexed keywords

DNA;

ARTICLE; CANCER GRADING; CANCER INVASION; CANCER STAGING; CELL PROLIFERATION; CLINICAL FEATURE; GENE AMPLIFICATION; GENE EXPRESSION; HIGH RISK PATIENT; HUMAN; ONCOGENE; PATHOLOGY; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TREATMENT PLANNING;

BROMODEOXYURIDINE; CARCINOMA, SQUAMOUS CELL; CYCLIN D1; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MONOMERIC GTP-BINDING PROTEINS; MOUTH NEOPLASMS; NUCLEOLUS ORGANIZER REGION; NUCLEOSIDE-DIPHOSPHATE KINASE; ONCOGENE PROTEINS V-ERBB; PLOIDIES; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; RAS PROTEINS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033457978     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (104)

1. Muir CS, Waterhouse JAH, Mack S: Cancer incidence in five continents, vol.V Scientific Publication. Lyon, IARC, 1988.
2. Pindborg JJ: Epidemiological studies of oral cancer. Intern Dent J 27: 172-178, 1977.
3. Östman J, Anneroth G, Gustafsson H, Tavelin B: Malignant oral tumours in Sweden 1960-1989- an epidemiological study. Oral Oncol, Eur J Cancer 31B: 106-112, 1995.
4. Macfarlane GJ, Boyle P, Scully C: Oral cancer in Scotland: changing incidence and mortality. Br Med J 305: 1121-1123, 1992.
5. Hindle I and Nally F: Oral cancer: a comparative study between 1962-67 and 1980-84 in England and Wales. Br Dent J 170: 15-20, 1991.
6. Moller H: Changing incidence of cancer of the tongue, oral cavity and pharynx in Denmark. J Oral Pathol Med 18: 224-229, 1989.
7. Schön D, Bertz J, Hoffmeister H: Bevölkerungsbezogene Krebsregister in der Bundesrepublik Deutschland, Bd 2, München, Medizin, 1989.
8. Silveberg E and Lubera J. Cancer statistics, 1992. CA 40: 5-22, 1992.
9. Sankaranarayanan R. Oral cancer in India: an epidemiologic and clinical review. Oral Surg Oral Med Oral Pathol 69: 325-330, 1990.
10. Muir C, Weiland I: Upper aerodigestive tract cancers. Cancer 75: 147-153, 1995.
11. Ildstad ST, Tollerud DJ, Bigelow ME, Remensnyder JP: Squamous cell carcinoma of the head and neck at the Massachusetts General Hospital. A comparison of biologic characteristics in men and women. Surgery 99: 7-14, 1986.
12. Newman AN, Rice H, Ossoff RH, Sisson GA: Carcinoma of the tongue in persons younger than 30 years of age. Arch. Otolaryngol 109: 302-304, 183.
13. Usenius T, Kärjä J, Collan Y: Squamous cell carcinoma of the tongue in children. Cancer 60: 236-239, 1987.
14. Boring C, Squires T, Tong T: Cancer statistics, 1992, CA 42-21, 1992.
15. Moore C, Flynn MB, Greenberg RA: Evaluation of size in prognosis of oral cancer. Cancer 58: 158-162, 1986.
16. Beltrami CA, Desinan L, Rubini C: Prognostic factors in squamous cell carcinoma of the oral cavity. A retrospective study of 80 cases. Path Res Pract 188: 510-516, 1992.
17. Jones AS: Prognosis in mouth cancer: tumour factors. Oral Oncol, Eur J Cancer 30B: 8-15, 1994.
18. Baker SR and Krause CJ: Carcinoma of the lip. Laryngoscope 90: 9-23, 1980.
19. Nuutinem J and Karja J: Local and distant metastases in patients with surgically treated squamous cell carcinoma of the lip. Clin Otolaryngol 76: 415-419, 1981.
20. Frierson HF and Cooper PH: Prognostic factors in squamous cell carcinoma of the lower lip. Hum Pathol 17: 346-354, 1986.
21. Störkel S, Reichert T, Reiffen KA, Wagner W: EGFR and PCNA expression in oral squamous cell carcinomas. A valuable tool in estimating the patient's prognosis. Oral Oncol, Eur J Cancer 29B: 273-277, 1993.
22. Tytor M, Franzén G, Olofsson J: DNA pattern in oral cavity carcinomas in relation to clinical stage and histological grading. Path Res Pract 182: 202-206, 1987.
23. Hemmer J and Schön E: Cytogenetic progression in oral carcinoma: a DNA flow cytometric study on 317 cases. Int J Oncol 3: 635-640, 1993.
24. Baretton G, Li X, Stoll C, Fischer-Brandies E, Schmidt M, Löhrs U: Prognostic significance of DNA ploidy in oral squamous cell carcinomas. A retrospective flow and image cytometric study with comparison of DNA ploidy in excisional biopsy specimens and resection specimens primary tumors and lymph node metastases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 79: 68-76, 1995.
25. Tsai ST and Jin YT: Proliferating cell nuclear antigen (PCNA) expression in oral squamous cell carcinomas. J Oral Pathol Med 24: 313-315, 1995.
26. Teixeira G, Antonangelo L, Kowalski L, Saldiva P, Ferraz A, Fiho GS: Argyrophilic nucleolar organizer regions staining is useful in predicting recurrence-free interval in oral tongue and floor of mouth squamous cell carcinoma. Am J Surg 172: 684-688, 1996.
27. Werkmeister R, Brandt B. Joos U: The erbB oncogenes as prognostic markers in oral squamous cell carcinoma. Am J Surg 172: 681-683, 1996.
28. Ohtsuki K, Shintani S, Kimura N, Matsumura T: Immunohistochemical study on the nm23 gene product (NDP kinase) in oral squamous cell carcinoma. Oral Oncol, Eur J Cancer 33: 237-239, 1997.
29. Crissman JD, Gluckman J, Whiteley J, Quenelle D: Squamous cell carcinoma of the floor of the mouth. Head Neck Surg 3: 2-7, 1980.
30. Rollo J, Rozenbom CV, Thawley S, Korba A, Ogura J, Perez CA, Powers WE, Bauer WC: Squamous carcinoma of the base of the tongue. A clinicopathologic study of 81 cases. Cancer 47: 333-342, 1981.
31. Grandi C, Alloisio M, Moglia D, Podrecca S, Sala L, Salvatori P, Molinari R: Prognostic significance of lymphatic spread in head and neck carcinomas. Therapeutic implications. Head Neck Surg 8: 67-73, 1985.
32. Oreggia F, De Stefani E, Denco-Pellegrini H, Olivera L: Carcinoma of the tonsil. A retrospective analysis of prognostic factors. Arch Intern Med 109: 305-309, 1986.
33. Easson EC and Palmer MK: Prognostic factors in oral cancer. Clin Oncol 2: 191-202, 1976.
34. Henk and Langdon: Malignant tumours of the oral cavity. London, Edward Arnold, 1985.
35. Callery CD, Spiro RH, Strong EW: Changing trends in the menagement of squamous carcinoma of the tongue. Am J Surg 148: 449-454, 1984.
36. Hibbert J, Marks NJ, Winter PJH, Shaheen OH: Prognostic factors in oral carcinoma and their relation to clinical staging. Clin Otolaryng 8: 197-203, 1983.
37. Frazell EL and Lucas JC: Cancer of the tongue: report of the menagement of 1554 patients. Cancer 15: 1085-1099, 1962.
38. MacComb WS and Fletcher GH: Cancer of the head and neck. Baltimora, Williams and Wilkins, 1967.
39. Shaha AR, Spiro RH, Shah JP, Strong EW: Squamous carcinoma of the floor of the mouth. Am J Surg 148: 455-459, 1984.
40. Givens CD, Johns ME, Cantrell RW: Carcinoma of the tonsil. Analysis of 162 cases. Arch Otolaryngol 107: 730-734, 1981.
41. Ildstad ST, Bigelow ME, Remensnyder JP: Intra-oral cancer at the Massachusetts General Hospital. Squamous cell carcinoma of the floor of the mouth. Ann Surg 197: 34-41, 1983.
42. Ildstad ST, Bigelow ME, Remensnyder JP: Squamous cell carcinoma of the alveolar ridge and palate. A 15-year survey. Ann Surg 199: 445-453, 1984.
43. Marks JE, Smith PG, Sessions DG: Pharyngeal wall cancer. A reappraisal after comparison of treatment methods. Arch Otolaryngol 111: 79-85, 1985.
44. Hemmer J and Kreidler J: Flow cytometric DNA ploidy analysis of squamous cell carcinoma of the oral cavity. Cancer 66: 317-320, 1990.
45. Daniele E, Rodolico V, Leonardi V, Tralongo V: Prognosis in lower lip squamous cell carcinoma: assessment of tumor factors. Path Res Pract 194: 319-324, 1998.
46. Regueiro CA, Aragòn G, Millàn I, Valcàrcel FJ, de la Torre A, Magallàn R: Prognostic factors for local control, regional control and survival in oropharyngeal squamous cell carcinoma. Eur J Cancer 30A: 2060-2067, 1994.
47. Crissman JD, Liu W, Gluckman JL, Cummings G: Prognostic value of histopathologic parameters in squamous cell carcinoma of the oropharynx. Cancer 54: 2995-3001, 1984.
48. Shear M, Hawkins DM, Farr HW: The prediction of lymph node metastases from oral squamous cancer. Cancer 37: 1901-1907, 1976.
49. Shintani S, Matsuura H, Hasegawa Y, Nakayama B, Hasegawa H: Regional lymph node involvement affects the incidence of distant metastasis in tongue squamous cell carcinomas. Anticancer Res 15: 1573-1576, 1995.
50. Shah JP, Cendon RA, Farr HW, Strong EW: Carcinoma of the oral cavity: factors affecting treatment failure at the primary site and neck. Am J Surg 132: 504-507, 1976.
51. Bloom ND and Spiro RH: Carcinoma of the cheek mucosa: a retrospective analysis. Am J Surg 140: 556-559, 1980.
52. Trible WM and Dias A: Cervical node metastases: prognosis related to level and distribution. Arch Otolaryngol 79: 247-249, 1964.
53. Spiro RH, Alfonso AE, Farr HW, Strong EW: Cervical node metastases from epidermoid carcinoma of the oral cavity or oropharynx: a critical assessment of current staging. Am J Surg 128: 562-567, 1974.
54. Snow GB, Annyas AA, Van Slooten EA, Bartelink H, Hart AAM: Prognostic factors of neck node metastasis. Clin Otolaryngol 7: 185-192, 1982.
55. Johnson JT, Myers EN, Bedetti CD, Barnes EL, Schramm VL, Thearle PB: Cervical lymph node metastases: incidence and implications of extracapsular carcinoma. Arch Otolaryngol Head Neck Surg 111: 534-537, 1985.
56. O'Brien CJ, Smith JW, Soong SJ: Neck dissection with and without radiotherapy: prognostic factors, patterns of recurrence and survival. Am J Surg 152: 456-463, 1986.
57. Hirabayashi H, Koshii K, Uno K: Extracapsular spread of squamous cell carcinoma in neck lymph nodes: prognostic factor of laryngeal cancer. Laryngoscope 101: 502-506, 1991.
58. Pinsolle J, Pinsolle V, Majoufre C, Duroux S, Demeaux H, Siberchicot F: Prognostic value of histologic findings in neck dissections for squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 123: 145-148, 1997.
59. Pinsolle J, Demeaux H, Coustal B: Results of surgical treatment of T3 and T4 tumors of the oral cavity and oropharynx. Am J Surg 164: 587-591, 1992.
60. Mamelle G, Pampurik J, Luboinski B, Lancar R, Lusinchi A, Bosq J: Lymph node prognostic factors in head and neck squamous cell carcinomas. Am J Surg 168: 494-498, 1994.
61. Broders AC: Squamous epithelioma of the lip: a study of five hundred and thirty seven cases. JAMA 74: 656-664, 1920.
62. Broders AC: Carcinoma. Grading and practical application. Arch Pathol 2: 376-381, 1926.
63. Broders AC: The microscopic grading of cancer. Surg Clin North Am 21: 947-961, 1941.
64. Jakobsson PA, Eneroth CM, Killander D, Moberger G, Martensson B: Histologic classification and grading of malignancy in carcinoma of the larynx (a pilot study). Acta Radiol Ther Phys Biol 12: 1-8, 1973.
65. Anneroth G and Hansen LS: A methodologic study of histologic classification and grading of malignancy in oral squamous cell carcinoma. Scand J Dent Res 92: 448-468, 1984.
66. Bryne M, Koppang HS, Lilleng R, Stene T, Bang G, Dabelsteen E: New malignancy grading is a better prognostic indicator than Broders' grading in oral squamous cell carcinoma. J Oral Pathol Med 18: 432-437, 1989.
67. Bryne M, Nielsen K, Koppang HS, Debelsteen E: Reproducibility of two malignancy grading system with reportedly prognostic value for oral cancer patients. J Oral Pathol Med 20: 369-372, 1991.
68. Bryne M, Koppang HS, Lilleng R, Kierheim A: Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value. J Pathol 166: 375-381, 1992.
69. Thomson St Cl: The history of cancer of the larynx. J Laryngol 54: 61-87, 1939.
70. Anneroth G, Batsakis J, Luna M: Review of the literature and a recommended system of malignancy grading in oral squamous cell carcinomas. Scand J Dent Res 95: 229-249, 1987.
71. Rodolico V, Daniele E, Leonardi, Marra G, Luciani A, Settineri G, Tralongo V: Node status in lower lip squamous cell carcinoma in relation to tumor size, histological variables and DNA ploidy. Anticancer Res 18: 911-914, 1988.
72. Klijanienko J, El-Naggar AK, De Braund F, Rodriguez-Peralto JL, Rodriguez R, Itzhaki M, Russo A, Janot F, Luboinski B, Cvitkovic E: Tumor vascularization, mitotic index, histopatologic grade and DNA ploidy in the assessment of 114 head and neck squamous cell carcinomas. Cancer 75: 1649-1656, 1995.
73. Crissman JD, Makuch R, Budhraja M: Histopathologic grading of squamous cell carcinoma of the uterine cervix. An evaluation of 70 stage Ib patients. Cancer 55: 1590-1596, 1985.
74. Friedman HI, Cooper PH, Wanebo HJ: Prognostic and therapeutic use of microstaging of cutaneous squamous cell carcinoma of the trunk and extremities. Cancer 56: 1099-1105, 1985.
75. Spiro RH, Huvos AG, Wong GY, Spiro JD, Gnecco CA, Strong EW: Predictive value of tumor thickness of squamous carcinoma confined to the tongue and floor of the mouth. Am J Surg 152: 345-350, 1986.
76. Moore C, Kuhns JG, Greenberg RA: Thickness as prognostic aid in upper aerodigestive tract cancer. Arch Surg 121: 1410-1414, 1986.
77. Urist MM, O'Brien CJ, Soong S, Vischer DW, Maddox WA: Squamous cell carcinoma of the buccal mucosa: analysis of prognostic factors. Am J Surg 154: 411-414, 1987.
78. Byers RM, O'Brien J, Waxler J: The therapeutic and prognostic implications of nerve invasion in cancer of the lower lip. Int J Radiol Oncol Biol Phys 4: 215-219, 1978.
79. Alcalde RE, Shintani S, Yoshihama Y, Matsumura T: Cell proliferation and tumor angiogenesis in oral squamous cell carcinoma. Anticancer Res 15: 1417-1422, 1995.
80. Gleich LL, Biddinger PW, Duperier FD, Gluckman JL: Tumor angiogenesis as a prognostic indicator in T2-T4 oral cavity squamous cell carcinoma: a clinical-pathologic correlation. Head Neck 19: 276-280, 1997.
81. Dunstan S, Powe DG, Wilkinson M, Pearson J, Hewitt RE: The tumour stroma of oral squamous cell carcinomas show increased vascularity compared with adjacent host tissue. Br J Cancer 75: 559-565, 1977.
82. Hemmer J, Schön E, Kreidler J, Haase S: Prognostic implications of DNA ploidy in squamous cell carcinomas of the tongue assessed by flow cytometry. J Cancer Res Clin Oncol 116: 83-86, 1990.
83. Dawson AE, Norton JA, Weinberg DS: Comparative assessment of proliferative and DNA content in breast carcinoma by image analysis and flow cytometry. Am J Pathol 136: 1115-1124, 1990.
84. Tsai ST and Jin YT: Proliferating cell nuclear antigen (PCNA) expression in oral squamous cell carcinomas. J Oral Pathol Med 24: 313-315, 1995.
85. Lan HA, Zain RB, Saitoh M, Muramatsu Y, Shrestha P, Mori M: Proliferating cell nuclear antigen (PCNA) and p53 in epithelial dysplasia and squamous cell carcinoma of oral mucosa - a marker for poor tumor differentiation, increasing nuclear atypia and invasiveness? Anticancer Res 16: 3059-3066, 1996.
86. Lange D, Heyden A, Lie ES, Brandtzaeg P, Boysen M, Clausen OPF: Lack of prognostic significance for P53-overexpression and Ki-67-immunoreactivity in oral T1-2 squamous cell carcinomas. Oncol Rep 4: 737-742, 1997.
87. Mukhopadhyay D, Chatterjee R, Chakrahorty RN: Cytokinetic studies of oral cancer cells using bromodeoxyuridine labelling in relation to factors influencing prognosis. Oral Oncol, Eur J Cancer 31B: 32-36, 1995.
88. Hemmer J: In vitro bromodeoxyuridine labelling of squamous cell carcinomas of the oral cavity. Eur J Cancer 26: 113-115, 1990.
89. Sano K, Takahashi H, Fujita S, Inokuchi T, Okaba H, Tsuda N: Prognostic implication of silver-binding nucleolar organizer regions (AgNORs) in oral squamous cell carcinoma. J Oral Pathol Med 20: 53-56, 1991.
90. Hirsch SM, DuCanto J, Caldarlli DD: Nucleolar organizer regions in squamous cell carcinoma of the head and neck. Laryngoscope 102: 34-44, 1992.
91. Migaldi M, Criscuolo M, Zunarelli E, Lo Bianco L, Martinelli AM, Barbolini G: p120 and AgNOR nucleolar protein expression. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85: 189-146, 1998.
92. Nishioka H, Hiasa Y, Hayashi I, Kitahori Y, Konishi N, Sugimura M: Immunohistochemical detection of p53 oncoprotein in human oral squamous cell carcinomas and leukoplakias: comparison with proliferating cell nuclear antigen staining and correlation with clinicopathological findings. Oncology 50: 426-429, 1993.
93. Ogden GR, Kiddie RA, Lunny DP, Lane D: Assessment of p53 protein expression in normal, benign and malignant oral mucosa. J Pathol 166: 389-394, 1992.
94. Warnakulasuriya KAAS and Johnson NW: Association of overexpression of p53 oncoprotein with the state of cell proliferation in oral carcinoma. J Oral Pathol Med 23: 246-250, 1994.
95. Piffko J, Bànkfalvi A, Öfner D, Berens A, Tkotz T, Joos U, Böcker W, Schmid KW: Expression of p53 protein in oral squamous cell carcinomas and adjacent non-tumorous mucosa of the floor of the mouth: an archival immunohistochemical study using wet autoclave pretreatment for antigen retrieval. J Oral Pathol Med 24: 337-342, 1995.
96. Yan JJ, Tzeng CC, Jin YT: Overexpression of p53 protein in squamous cell carcinoma of buccal mucosa and tongue in Taiwan: an immunohistochemical and clinicopathological study. J Oral Pathol Med 25: 55-59, 1996.
97. Werkmeister R, Brandt B, Joos U: The erbB oncogenes as prognostic markers in oral squamous cell carcinomas. Am J Surg 172: 681-683, 1996.
98. Field JK, Spandidos DA, Yiagnisis M: C-erbB-e expression in squamous cell carcinoma of the head and neck. Anticancer Res 12: 613-620, 1992.
99. Yeudall WA, Torrance LK, Elsegood KA, Speight P, Scully C, Prime SS: Ras gene point mutation is a rare event in premalignant tissues and malignant cells and tissues from oral mucosal lesions. Oral Oncol, Eur J Cancer 29: 63-67, 1993.
100. Azuma M, Furumoto N, Kawamata H: The relation of ras oncogene product p21 expression to clinicopathological status criteria and clinical outcome in squamous cell head and neck cancer. The Cancer J 1: 375-380, 1987.
101. Tsuji T, Sasaki K, Hiraoka F, Shinozaki F: The immunohistochemical detection of ras p21 and its correlation with differentiation in oral cancers. J Tumor Marker Oncol 4: 415-419, 1989.
102. Michalides R, van Veelen N, Kristel P, Hart A, Loftus B, Hilgers F, Balm A: Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 123: 497-502, 1997.
103. Michalides R, van Veelen N, Hart A, Loftus B, Wientijens E, Balm A: Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 55: 975-978, 1995.
104. Wang X, Pavelic ZP, Li YQ, Gleich L, Radack K, Gluckman JL, Stambrook PJ: Amplification and Overexpression of the cyclin D1 gene in head neck squamous cell carcinoma. J Clin Pathol 48: 256-259, 1995.